SCHEDULE: Point72 Discloses 8.0% Stake in Invivyd, Inc.

Point72 Asset Management, along with Point72 Capital Advisors Inc. and Steven A. Cohen, has disclosed an 8.0% beneficial ownership stake in Invivyd, Inc.

Summary

• Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen collectively reported beneficial ownership of 16,730,467 shares of Invivyd, Inc. common stock.
• This represents an 8.0% stake in the company's outstanding common stock.
• The ownership is primarily held through Point72 Associates, an investment fund managed by Point72 Asset Management.
• Steven A. Cohen controls both Point72 Asset Management and Point72 Capital Advisors Inc.
• The filing indicates a passive investment, not intended to change or influence control of the issuer, other than activities solely in connection with a nomination under Rule 240.14a-11.
• The percentage of class is based on 209,377,291 shares outstanding as of August 22, 2025, following Invivyd's underwritten public offering and the full exercise of the underwriter's option.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive stake by a reputable institutional investor like Point72 Asset Management is generally viewed positively, indicating investor confidence without suggesting immediate disruptive intent.

Positives

• A significant institutional investor, Point72 Asset Management, has taken an 8.0% stake in Invivyd, Inc., potentially signaling confidence in the company's future prospects.
• The investment is stated to be passive, suggesting no immediate intent to disrupt current management or strategy.

Negatives

• No specific negative information is disclosed in this Schedule 13G filing.

Risks

• No specific risks related to Invivyd, Inc.'s operations or financial health are disclosed in this Schedule 13G filing, as it pertains solely to beneficial ownership.

Future Outlook

The filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding Invivyd, Inc.'s future operations or financial performance.

Industry Context

The disclosure of a significant stake by a prominent hedge fund like Point72 Asset Management in a company like Invivyd, Inc. (likely a biotech or pharmaceutical firm given the nature of its public offering and typical investor interest) can be seen as a vote of confidence in the company's long-term potential or its specific pipeline/market position. Such investments often attract further investor attention to the sector or specific company.

Stakeholder Impact

• Shareholders may view the investment by Point72 Asset Management as a positive signal, potentially increasing investor confidence and attracting further interest in Invivyd, Inc.'s stock.
• The passive nature of the investment suggests no immediate impact on employees, customers, or suppliers, as there is no stated intent to influence company control or operations.

Next Steps

• The filing does not specify any future actions, events, or milestones for Invivyd, Inc. or the reporting persons beyond regulatory compliance.

Key Dates

Recommendation

While the disclosure of a significant institutional stake by Point72 Asset Management is a positive signal, this filing alone does not provide sufficient operational or financial details about Invivyd, Inc. to warrant a 'buy' or 'sell' recommendation. It primarily indicates a large investor's position. Investors should 'hold' and await further fundamental analysis or company-specific news before making a more definitive investment decision.

Keywords

Invivyd Inc, Point72 Asset Management, Steven A. Cohen, Beneficial Ownership, Schedule 13G, Institutional Investment, Common Stock, Biotechnology, Healthcare